<DOC>
	<DOCNO>NCT02631499</DOCNO>
	<brief_summary>This study design prospectively evaluate whether post-hepatectomy adjuvant transcatheter arterial chemoembolization ( TACE ) effective reduce early recurrence HCC patient preoperative CTC ≥2 .</brief_summary>
	<brief_title>Efficacy Study TACE Treat Hepatocellular Carcinoma After Operation</brief_title>
	<detailed_description>Hepatocellular carcinoma ( HCC ) one prevalent malignancy worldwide , associate morbidity mortality rate escalate recent year . Despite improvement surveillance clinical treatment strategy , prognosis HCC remain poor due high incidence recurrence metastasis . Recent clinical study provide evidence circulate tumor cell ( CTC ) may directly participate metastasis cascade various type malignancy . The investigator previous data indicate HCC patient preoperative CTC level ≥2 suffer significantly early recurrence ( within 1 year ) patient low level . However , benefit postoperative adjuvant therapy prevent early recurrence patient preoperative CTC ≥2 remain elucidated . Transarterial chemoembolisation ( TACE ) effective palliative treatment HCC . The investigator design randomise controlled trial evaluate efficacy use TACE hepatectomy reduce early recurrence rate HCC patient preoperative CTC level ≥2 .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<mesh_term>Ethiodized Oil</mesh_term>
	<criteria>HCC patient receive curative hepatectomy negative resection margin Age 18 75 ChildPugh class A ASA class I II ECOG performance status Grade 0 1 Preoperative CTC level ≥2 per 7.5 ml peripheral blood No residual tumor reveal hepatic arterial angiography 46 week hepatectomy Patients diagnose type malignancy besides HCC Patients receive concomitant local ablation previous TACE Main portal vein tumor thrombus extraction hepatectomy Hepatic arterial angiography adjuvant TACE treatment reveals residual tumor . Presence extrahepatic lymphatic metastasis Impaired liver function either clinically detect ascites , hepatic encephalopathy , serum albumin &lt; 25g/L bilirubin &gt; 50micromol/L Renal impairment creatinine &gt; 200micromol/L Severe concurrent medical illness persist &gt; 6 week hepatectomy History cancer Hepatic artery anomaly make TACE possible Allergy 5Fluorouracil , Epirubicin lipiodol Pregnant woman Informed consent available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Circulating Tumor Cells</keyword>
	<keyword>Hepatoectomy</keyword>
	<keyword>TACE</keyword>
	<keyword>prognosis</keyword>
	<keyword>relapse</keyword>
	<keyword>Chemoembolization , Therapeutic</keyword>
</DOC>